logo
Protagonist Therapeutics Reports Granting of Inducement Award

Protagonist Therapeutics Reports Granting of Inducement Award

NEWARK, CA / ACCESS Newswire / April 16, 2025 / Protagonist Therapeutics, Inc. ('Protagonist' or the 'Company'), a clinical-stage biopharmaceutical company pioneering the discovery and development of peptide-based therapeutics, today announced that on April 15, 2025 (the 'Grant Date'), it issued an equity inducement award to a new employee upon his commencement of employment with the Company in accordance with the terms of his employment offer letter. The award was granted under the Company's Amended and Restated 2018 Inducement Plan, which was adopted on May 29, 2018, and amended on February 18, 2020 and February 15, 2022.
The new employee received options to purchase 20,000 shares of the Company's common stock on the Grant Date. The exercise price of the options is equal to $46.95, the closing price of the Company's common stock on the Nasdaq Stock Market on the Grant Date. The options will vest over a four-year period, with 25 percent of the options vesting on the first anniversary of the employee's start date and the remainder vesting in equal monthly installments over three years thereafter. The award was approved by the Compensation Committee of the Company's Board of Directors and was granted as a material inducement to the employee's entering into employment with the Company in accordance with Nasdaq Marketplace Rule 5635(c)(4).
About Protagonist Therapeutics
Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. Two novel peptides, icotrokinra and rusfertide, derived from Protagonist's proprietary discovery platform are currently in advanced Phase 3 clinical development, with New Drug Application submissions to the FDA expected in 2025. Icotrokinra (JNJ-2113) is a first-in-class investigational targeted oral peptide that selectively blocks the Interleukin-23 receptor ('IL-23R') which is licensed to Janssen Biotech, Inc., a Johnson & Johnson company. Following icotrokinra's joint discovery by Protagonist and Johnson & Johnson scientists pursuant to the companies' IL-23R collaboration, Protagonist was primarily responsible for development of icotrokinra through Phase 1, with Johnson & Johnson assuming responsibility for development in Phase 2 and beyond. Rusfertide, a mimetic of the natural hormone hepcidin, is currently in Phase 3 development for the rare blood disorder polycythemia vera (PV). Rusfertide is being co-developed and will be co-commercialized with Takeda Pharmaceuticals pursuant to a worldwide collaboration and license agreement entered into in 2024 under which the Company remains primarily responsible for development through NDA filing. The Company also has a number of pre-clinical stage oral drug discovery programs addressing clinically and commercially validated targets, including the IL-17 oral peptide antagonist PN-881, an oral hepcidin program, and an oral obesity program.
More information on Protagonist, its pipeline drug candidates and clinical studies can be found on the Company's website at protagonist-inc.com.
Investor Relations Contact
Corey Davis, Ph.D.
LifeSci Advisors
+1 212 915 2577
[email protected]
Media Contact
Virginia Amann, Founder/CEO
ENTENTE Network of Companies
+1 833 500 0061 ext 1
[email protected]
SOURCE: Protagonist Therapeutics
press release
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Deere & Company (DE) Just Needs To Be More Optimistic, Asserts Jim Cramer
Deere & Company (DE) Just Needs To Be More Optimistic, Asserts Jim Cramer

Yahoo

time27 minutes ago

  • Yahoo

Deere & Company (DE) Just Needs To Be More Optimistic, Asserts Jim Cramer

We recently published . Deere & Company (NYSE:DE) is one of the stocks Jim Cramer recently discussed. Deere & Company (NYSE:DE) is an agricultural and construction equipment company. Cramer has discussed the firm several times on his morning show in 2025. Most of his remarks have revolved around Deere & Company (NYSE:DE)'s exposure to AI data center construction activity in the US and fresh legislation, both of which can act as tailwinds for the firm. The firm's shares dipped by 6.8% in August after it narrowed its full-year outlook. Cramer discussed Deere & Company (NYSE:DE) in the context of AgCo: 'I do think that Deere, I thought that might be a bounce back. Because we had AgCo on last night. And AgCo was being very, very positive. . .but AgCo's not as US-centric. It is a mystery to me that Deere's down this much given the fact that inventories don't seem to be a problem. And given the fact that AgCo, its principle competitor, just is crushing it, crushing. mark smith nsb/ Here are the CNBC TV host's previous comments about Deere & Company (NYSE:DE): 'In May of last year, I told you that Deere was finally taking control of its own destiny, even if that might… take some time to play out. And in retrospect, that was a good call… Funny thing about Deere, while the stock's roared over the past 12 months, the company hasn't been putting up particularly good numbers… But even though the numbers have been hideous in absolute terms, Deere's results have consistently come in better than expected. How's it possible? Simple. This company is hostage to the agriculture market, which means their business rise[s] and falls based on factors that they've got, let's say, no control over… While we acknowledge the potential of DE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

D. Boral ARC Acquisition I Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing August 20, 2025
D. Boral ARC Acquisition I Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing August 20, 2025

USA Today

time28 minutes ago

  • USA Today

D. Boral ARC Acquisition I Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing August 20, 2025

NEW YORK, NY / ACCESS Newswire / August 19, 2025 / D. Boral ARC Acquisition I Corp. (the 'Company') today announced that, commencing August 20, 2025, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on The Nasdaq Global Market under the symbols 'BCAR' and 'BCARW,' respectively. Those units not separated will continue to trade on The Nasdaq Global Market under the symbol 'BCARU.' Holders of units will need to have their brokers contact Odyssey Transfer and Trust Company, the Company's transfer agent, in order to separate the units into Class A ordinary shares and warrants. A registration statement on Form S-1 relating to these securities was declared effective by the SEC on July 30, 2025. The offering was made only by means of a prospectus. Copies of the prospectus relating to the offering may be obtained from D. Boral Capital LLC: Attn: 590 Madison Avenue 39th Floor, New York, NY 10022, or by email at dbccapitalmarkets@ or by telephone at (212) 970-5150, or from the U.S. Securities and Exchange Commission's (the 'SEC') website at This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About D. Boral ARC Acquisition I Corp. The Company was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an acquisition opportunity in any business, industry, sector or geographical location, the Company intends to identify and acquire a business where the Company believes its management teams' and affiliates' expertise will provide a competitive advantage, including the technology, healthcare, and logistics industries. Forward-Looking Statements This press release contains statements that constitute 'forward-looking statements,' including with respect to the Company's search for an initial business combination. No assurance can be given that the Company will ultimately complete a business combination transaction in the sectors it is targeting or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and prospectus for the IPO filed with the SEC. Copies are available on the SEC's website, The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. Contact John Darwin, Chief Financial Officer Email: contact@ SOURCE: D. Boral Capital View the original press release on ACCESS Newswire

Pulsar Helium Announces Fundraise of Up to GBP 5 Million
Pulsar Helium Announces Fundraise of Up to GBP 5 Million

Associated Press

timean hour ago

  • Associated Press

Pulsar Helium Announces Fundraise of Up to GBP 5 Million

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT ITSELF CONSTITUTE AN OFFER FOR SALE OR SUBSCRIPTION OF ANY SECURITIES IN THE COMPANY. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION, OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE OR DISPOSE OF ANY SECURITIES OF THE COMPANY IN ANY JURISDICTION WHERE TO DO SO WOULD BREACH ANY APPLICABLE LAW OR REGULATION. THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) NO. 596/2014 ON MARKET ABUSE ('UK MAR'), AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AND REGULATION (EU) NO. 596/2014 ON MARKET ABUSE ('EU MAR'). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION. NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. CASCAIS, PORTUGAL / ACCESS Newswire / August 20, 2025 / Pulsar Helium Inc. (AIM:PLSR)(TSXV:PLSR)(OTCQB:PSRHF) ('Pulsar' or the 'Company'), a leading helium project development company, is pleased to announce that it intends to complete a private placement financing by way of an accelerated bookbuild (the 'Offering') of a minimum of 13,043,478 common shares of the Company (each, a 'Common Share') at a price of GBP 0.23 (approximately CAD$0.43)per Common Share (the 'Issue Price') to raise minimum gross proceeds of GBP 3,000,000 (approximately CAD$5,610,000) and a maximum of 21,739,130 Common Shares at the Issue Price to raise maximum gross proceeds of GBP 5,000,000 (approximately CAD$9,350,000). The Offering will be conducted by way of an accelerated bookbuild process managed by OAK Securities as exclusive bookrunner. The bookbuild will open immediately following this announcement. The timing of the closing of the bookbuild and allocations are at the absolute discretion of OAK Securities and the Company. It is currently envisaged that the result of bookbuild will be announced by the Company at approximately 07:00 (UK time) on August 21, 2025. Net proceeds received pursuant to the Offering will be used to advance Pulsar's flagship Topaz helium project in Minnesota, USA and for general working capital purposes. Specifically, upon closing of the Offering, the Company intends to sign a new contract for drilling of up to 10 new appraisal wells, to further define the size and shape of the helium-bearing reservoir. Other activities to be funded from the net proceeds of the Offering within the coming 12 months include a preliminary economic assessment and resource update. Closing of the Offering (and associated admission to trading on AIM of the new Common Shares issued pursuant to the Offering) is anticipated to occur on or about August 29, 2025 ('Closing'), subject to the satisfaction of certain conditions, including, but not limited to, the receipt of all necessary regulatory and other approvals. The Company has been informed by University Bancorp Inc, its c. 5% shareholder and principal lender, that it intends to participate in the Offering in order to maintain its equity interest. Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 - Prospectus Exemptions ('NI 45-106"), the Common Shares issuable under the Offering will be offered for sale to purchasers resident in the UK and all of the provinces of Canada (except Quebec) pursuant to the listed issuer financing exemption under Part 5A.2 of NI 45-106 (the 'LIFE Exemption'). As such, the securities issued to subscribers will not be subject to resale restrictions in accordance with applicable Canadian securities laws. There is an offering document (the 'Offering Document') dated August 20, 2025 related to the Offering and prepared pursuant to the CSA's Listed Issuer Financing Exemption that can be accessed under the Company's profile at and on the Company's website at This Offering Document contains additional details regarding the Offering, including additional details regarding the expected use of proceeds therefrom. Prospective investors in the Offering should read this Offering Document before making an investment decision. The Offering Document does not contain an offer of transferable securities to the public in the United Kingdom within the meaning of section 102B of the Financials Services and Markets Act 2000, as amended ('FSMA') and is not required to be issued as a prospectus pursuant to section 85 of FSMA. It has not been, nor will it be approved by, or filed with, the Financial Conduct Authority or any other authority which would be a competent authority for the purposes of the UK Prospectus Regulation. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the 'U.S. Securities Act'), or any United States state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or any available exemption from the registration requirements of the U.S. Securities Act and applicable United States state securities laws. This press release does not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. Pulsar has appointed OAK Securities (a trading name of Merlin Partners LLP), to act as the Company's exclusive bookrunner and placement agent in connection with the Offering to UK residents pursuant to a placing agreement. OAK Securities will be paid an advisory fee of £20,000, payable in cash and a cash fee in an amount equal to six per cent (6.0%) of the gross proceeds raised from UK resident investors introduced to the Company by OAK Securities pursuant to the Offering. The Company will also issue Common Share purchase warrants (the 'Broker Warrants') to OAK Securities equal to 6.0% of the number of Common Shares acquired by investors introduced to the Company by OAK Securities pursuant to the Offering, with such Broker Warrants being exercisable for 12 months from the date of issue at a price of GBP 0.23 (approximately CAD$0.43).OAK Securities has the right to terminate the placing agreement where, at its sole discretion (but in consultation with the Company), due to a change in market, economic or financial conditions, the Offering is rendered temporarily or permanently impracticable or inadvisable. The new Common Shares, when issued and fully paid, will rank pari passu in all respects with the existing Common Shares in issue and therefore will rank equally for all dividends or other distributions declared, made or paid after the issue of the new Common Shares. Completion of the Offering, is subject to certain closing conditions including, but not limited to, the receipt of all necessary approvals including receipt of conditional approval from the TSX Venture Exchange. On behalf Pulsar Helium Inc. 'Thomas Abraham-James' President, CEO and Director Further Information: Pulsar Helium Inc. [email protected] + 1 (218) 203-5301 (USA/Canada) +44 (0) 2033 55 9889 (United Kingdom) Strand Hanson Limited (Nominated & Financial Adviser, and Joint Broker) Ritchie Balmer / Rob Patrick +44 (0)20 7409 3494 OAK Securities* (Joint Broker) Richard McGlashan / Mungo Sheehan +44 7879 646641 / +44 7788 266844 [email protected] / [email protected] *OAK Securities is the trading name of Merlin Partners LLP, a firm incorporated in the United Kingdom and regulated by the UK Financial Conduct Authority. Yellow Jersey (Financial PR) Charles Goodwin / Annabelle Wills +44 777 5194 357 [email protected] About Pulsar Helium Inc. Pulsar Helium Inc. is a publicly traded company quoted on the AIM market of the London Stock Exchange and listed on the TSX Venture Exchange with the ticker PLSR, as well as on the OTCQB with the ticker PSRHF. Pulsar's portfolio consists of its flagship Topaz helium project in Minnesota, USA, and the Tunu helium project in Greenland. Pulsar is the first mover in both locations with primary helium occurrences not associated with the production of hydrocarbons identified at each. Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the 'U.S. Securities Act') or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Forward-Looking Statements This news release and the interview contains forward-looking information within the meaning of Canadian securities legislation (collectively, 'forward-looking statements') that relate to the Company's current expectations and views of future events. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as 'will likely result', 'are expected to', 'expects', 'will continue', 'is anticipated', 'anticipates', 'believes', 'estimated', 'intends', 'plans', 'forecast', 'projection', 'strategy', 'objective' and 'outlook') are not historical facts and may be forward-looking statements. Forward-looking statements herein include, but are not limited to, statements relating relating to the expected date of Closing of the Offering and the expected use of net proceeds of the Offering. Forward-looking statements may involve estimates and are based upon assumptions made by management of the Company, including, but not limited to, the Company's capital cost estimates, management's expectations regarding the availability of capital to fund the Company's future capital and operating requirements and the ability to obtain all requisite regulatory approvals. No reserves have been assigned in connection with the Company's property interests to date, given their early stage of development. The future value of the Company is therefore dependent on the success or otherwise of its activities, which are principally directed toward the future exploration, appraisal and development of its assets, and potential acquisition of property interests in the future. No un-risked Contingent and Prospective Helium Volumes have been defined at the Tunu Project. However, estimating helium volumes is subject to significant uncertainties associated with technical data and the interpretation of that data, future commodity prices, and development and operating costs. There can be no guarantee that the Company will successfully convert its helium volume to reserves and produce that estimated volume. Estimates may alter significantly or become more uncertain when new information becomes available due to for example, additional drilling or production tests over the life of field. As estimates change, development and production plans may also vary. Downward revision of helium volume estimates may adversely affect the Company's operational or financial performance. Helium volume estimates are expressions of judgement based on knowledge, experience and industry practice. These estimates are imprecise and depend to some extent on interpretations, which may ultimately prove to be inaccurate and require adjustment or, even if valid when originally calculated, may alter significantly when new information or techniques become available. As further information becomes available through additional drilling and analysis the estimates are likely to change. Any adjustments to volume could affect the Company's exploration and development plans which may, in turn, affect the Company's performance. The process of estimating helium resources is complex and requires significant decisions and assumptions to be made in evaluating the reliability of available geological, geophysical, engineering, and economic date for each property. Different engineers may make different estimates of resources, cash flows, or other variables based on the same available data. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company's control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward- looking statements. Such risks and uncertainties include, but are not limited to, that Pulsar may be unsuccessful in drilling commercially productive wells; the uncertainty of resource estimation; operational risks in conducting exploration, including that drill costs may be higher than estimates ; commodity prices; health, safety and environmental factors; and other factors set forth above as well as risk factors included in the Company's Annual Information Form dated July 31, 2025 for the year ended September 30, 2024 found under Company's profile on Forward-looking statements contained in this news release are as of the date of this news release, and the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for the Company to predict all of them or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. No assurance can be given that the forward-looking statements herein will prove to be correct and, accordingly, investors should not place undue reliance on forward-looking statements. Any forward-looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement. APPENDIX TERMS AND CONDITIONS OF THE OFFERING IMPORTANT INFORMATION ON THE OFFERING FOR INVITED PLACEES ONLY. MEMBERS OF THE PUBLIC ARE NOT ELIGIBLE TO TAKE PART IN THE OFFERING. THIS ANNOUNCEMENT DOES NOT ITSELF CONSTITUTE AN OFFER FOR THE SALE OR SUBSCRIPTION OF ANY SECURITIES IN THE COMPANY. THIS ANNOUNCEMENT (INCLUDING THIS APPENDIX) (THE 'ANNOUNCEMENT') IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, JAPAN, THE REPUBLIC OF IRELAND THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL. The price of shares and any income expected from them may go down as well as up and investors may not get back the full amount invested upon disposal of the shares. Past performance is no guide to future performance and persons needing advice should consult an independent financial adviser. These Terms and Conditions do not constitute an offer or invitation to acquire, underwrite or dispose of, or any solicitation of any offer or invitation to acquire, underwrite or dispose of, any new Common Shares or other securities of the Company to any person in any jurisdiction to whom it is unlawful to make such offer, invitation or solicitation in such jurisdiction. Persons who seek to participate in the Offering ('Placees') must inform themselves about and observe any such restrictions and must be persons who are able to lawfully receive this Announcement in their jurisdiction. In particular, these Terms and Conditions do not constitute an offer or invitation (or a solicitation of any offer or invitation) to acquire, underwrite or dispose of or otherwise deal in any new Common Shares or other securities of the Company in the United States of America, its territories and possessions ('United States'), Australia, Japan, Republic of Ireland or the Republic of South Africa or in any other jurisdiction in which any such offer, invitation or solicitation is or would be unlawful ('Restricted Jurisdiction'). The new Common Shares to be issued pursuant to the Offering (the 'Offering Shares') have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the 'Securities Act') or under the securities laws or with any securities regulatory authority of any state or other jurisdiction of the United States and may not be offered, sold, taken up, renounced, delivered or transferred, directly or indirectly, in the United States or to or by a person resident in or for the account of any person in the United States absent registration under the Securities Act or pursuant to an available exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. No public offering of the Offering Shares is being made in the United Kingdom or elsewhere. Members of the public are not eligible to take part in the Offering and no public offering of Offering Shares is being or will be made. This Announcement and the terms and conditions set out and referred to in it are directed only at persons selected by OAK Securities who are (a) if in the United Kingdom, persons who (i) have professional experience in matters relating to investments falling within article 19(1) of The Financial Services and Markets Act (Financial Promotion) Order 2005, as amended ('FPO') and who fall within the definition of 'investment professionals' in article 19(5) of the FPO or fall within the definition of 'high net worth companies, unincorporated associations etc.' in article 49(2)(a) to (d) of the FPO and (ii) are 'qualified investors' ('UK Qualified Investors') being persons within the meaning of article 2(e) of Regulation (EU) 2017/1129 (as amended) as it forms part of UK domestic law by virtue of, the European Union (Withdrawal) Act 2018 (as amended) (the 'UK Prospectus Regulation'); (b) if in a member state of the European Economic Area ('EEA'), persons who are 'qualified investors' ('EEA Qualified Investors') being persons falling within the meaning of article 2(e) of Regulation (EU) 2017/1129 (as amended) (the 'EU Prospectus Regulation'); or (c) persons to whom it may otherwise lawfully be communicated (all such persons referred to in (a), (b) and (c) together being referred to as 'Relevant Persons'). No action has been taken by the Company, OAK Securities, or any of their respective directors, officers, partners, agents, employees or affiliates that would permit an offer of the Offering Shares or possession or distribution of this Announcement or any other publicity material relating to such Offering Shares in any jurisdiction where action for that purpose is required. Persons receiving this Announcement are required to inform themselves about and to observe any restrictions contained in this Announcement. This Announcement does not itself constitute an offer for sale or subscription of any securities in the Company. This Announcement and the terms and conditions set out herein must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this Announcement relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. Distribution of this Announcement in certain jurisdictions may be restricted or prohibited by law. Persons distributing this announcement must satisfy themselves that it is lawful to do so. These Terms and Conditions apply to Placees, each of whom confirms his or its agreement, whether by telephone or otherwise, with OAK Securities, the sole broker, to subscribe and pay for Offering Shares in the Offering, and hereby agrees with OAK Securities and the Company to be legally and irrevocably bound by these Terms and Conditions which will be the Terms and Conditions on which the Offering Shares will be acquired in the Offering and each such Placee is deemed to have read and understood this Announcement in its entirety (including this Appendix) and to be providing the representations, warranties, undertakings, agreements and acknowledgements contained in this Appendix. These Terms and Conditions must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which the Terms and Conditions set out herein relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. A Placee may not assign, transfer, or in any manner, deal with its rights or obligations under the agreement arising from the acceptance of the Offering, without the prior written agreement of OAK Securities or in accordance with all relevant requirements. All times and dates in this Appendix are references to times and dates in London (United Kingdom). Any indication in this Announcement of the price at which the Company's shares have been bought or sold in the past cannot be relied upon as a guide to future performance. Persons needing advice should consult an independent financial adviser. No statement in this Announcement is intended to be a profit forecast and no statement in this Announcement should be interpreted to mean that earnings per share of the Company for the current or future financial years would necessarily match or exceed the historical published earnings per share of the Company. OAK Securities is a trading name of Merlin Partners LLP, which is authorised and regulated by the FCA in the United Kingdom. OAK Securities is acting exclusively for the Company and for no one else in connection with the Offering and will not be responsible to anyone other than the Company for providing the protections afforded to clients of OAK Securities or for providing advice in relation to the Offering, or any other matters referred to in this Announcement. Save for the responsibilities and liabilities, if any, of OAK Securities under FSMA or the regulatory regime established thereunder or in respect of fraudulent misrepresentation, no representation or warranty, express or implied, is or will be made as to, or in relation to, and no responsibility or liability is or will be accepted by or on behalf of OAK Securities or by its affiliates, agents, directors, officers and employees as to, or in relation to, the accuracy or completeness of this Announcement or any other written or oral information made available to or publicly available to any interested party or its advisers, and any liability therefor is expressly disclaimed. EACH PLACEE SHOULD CONSULT WITH ITS OWN ADVISERS AS TO LEGAL, REGULATORY, TAX, BUSINESS AND RELATED ASPECTS OF AN ACQUISITION OF PLACING SHARES. Persons who are invited to and who choose to participate in the Offering, by making an oral or written offer to acquire Offering Shares, including any individuals, funds or others on whose behalf a commitment to acquire Offering Shares is given, will be deemed to have read and understood this Announcement in its entirety and to be making such offer on these Terms and Conditions, and to be providing the representations, warranties, acknowledgements and undertakings, contained in this Appendix. In particular, each such Placee represents, warrants and acknowledges that:- i. it is a Relevant Person (as defined above) and undertakes that it will acquire, hold, manage or dispose of any Offering Shares that are allocated to it for the purposes of its business; ii. it is acquiring the Offering Shares for its own account or for an account with respect to which it exercises sole investment discretion; iii. if it is in the United Kingdom and/or if it is a financial intermediary, as that term is used in Article 5(1) of the UK Prospectus Regulation, any Offering Shares acquired by it in the Offering will not be acquired or subscribed for on a non-discretionary basis on behalf of, nor will they be acquired or subscribed for with a view to their offer or resale to persons in the United Kingdom other than to UK Qualified Investors or in circumstances which may give rise to an offer of securities to the public other than an offer or resale in the United Kingdom to UK Qualified Investors, or in circumstances in which the prior consent of OAK Securities has been given to each such proposed offer or resale; and iv. if it is in a member state of the EEA and/or if it is a financial intermediary, as that term is used in Article 5(1) of the EU Prospectus Regulation, any Offering Shares acquired or subscribed for by it in the Placing will not be acquired on a non-discretionary basis on behalf of, nor will they be acquired or subscribed for with a view to their offer or resale to persons in any member state of the EEA other than to EEA Qualified Investors or in circumstances which may give rise to an offer of securities to the public other than an offer or resale in a member state of the EEA to EEA Qualified Investors, or in circumstances in which the prior consent of OAK Securities has been given to each such proposed offer or resale. OAK Securities does not make any representation to any Placees regarding an investment in the Offering Shares. In this Appendix, unless the context otherwise requires, 'Placee' means a Relevant Person (including individuals, funds or others) by whom or on whose behalf a commitment to take up Offering Shares has been given and who has been invited to participate in the Placing by OAK Securities. All obligations of OAK Securities under the Offering will be subject to fulfilment of the conditions referred to in this Announcement, including (without limitation) those referred to below under 'Conditions of the Offering'. Information to Distributors Solely for the purposes of the product governance requirements of Chapter 3 of the FCA Handbook Product Intervention and Product Governance Sourcebook (the 'UK Product Governance Requirements'), and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any 'manufacturer' (for the purposes of the UK Product Governance Requirements) may otherwise have with respect thereto, the Offering Shares have been subject to a product approval process, which has determined that the Offering Shares are: (i) compatible with an end target market of 'retail investors' and investors who meet the criteria of 'professional clients' and 'eligible counterparties', each as defined in the FCA Conduct of Business Sourcebook; and (ii) eligible for distribution through all permitted distribution channels (the 'UK Target Market Assessment'). Solely for the purposes of the product governance requirements contained within: (a) EU Directive 2014/65/EU on markets in financial instruments, as amended ('MiFID II'); (b) Articles 9 and 10 of Commission Delegated Directive (EU) 2017/593 supplementing MiFID II; and (c) local implementing measures (together, the 'MiFID II Product Governance Requirements') and/or any equivalent requirements elsewhere to the extent determined to be applicable, and disclaiming all and any liability, whether arising in tort, contract or otherwise, which any 'manufacturer' (for the purposes of the MiFID II Product Governance Requirements) may otherwise have with respect thereto, the Offering Shares have been subject to a product approval process, which has determined that the Offering Shares are: (i) compatible with an end target market of 'retail investors' and investors who meet the criteria of 'professional clients' and 'eligible counterparties', each as defined in MiFID II; and (ii) eligible for distribution through all distribution channels as are permitted by MiFID II (the 'EU Target Market Assessment' and, together with the UK Target Market Assessment, the 'Target Market Assessments'). Notwithstanding the Target Market Assessments, distributors should note that: the price of the Offering Shares may decline and investors could lose all or part of their investment; the Offering Shares offer no guaranteed income and no capital protection; and an investment in the Offering Shares is compatible only with investors who do not need a guaranteed income or capital protection, who (either alone or in conjunction with an appropriate financial or other adviser) are capable of evaluating the merits and risks of such an investment and who have sufficient resources to be able to bear any losses that may result therefrom. The Target Market Assessments are without prejudice to the requirements of any contractual, legal or regulatory selling restrictions in relation to the Offering. Furthermore, it is noted that, notwithstanding the Target Market Assessments, OAK Securities will only procure investors who meet the criteria of 'professional clients' or 'eligible counterparties'. For the avoidance of doubt, the Target Market Assessments do not constitute: (a) an assessment of suitability or appropriateness for the purposes of Chapters 9A or 10A, respectively of the FCA Handbook Conduct of Business Sourcebook (for the purposes of the UK Target Market Assessment) or MiFID II (for the purposes of the EU Target Market Assessment); or (b) a recommendation to any investor or group of investors to invest in, or purchase, or take any other action whatsoever with respect to the Offering Shares. Each distributor is responsible for undertaking its own target market assessment in respect of the Offering Shares and determining appropriate distribution channels. Timetable for the Offering Various dates referred to in this Announcement are stated on the basis of the expected timetable for the Offering. It is possible that some of these dates may be changed. The Offering Shares will be allotted on 29 August 2025 subject to the satisfaction of certain conditions, including, but not limited to, the receipt of all necessary regulatory and other approvals. Terms of the Offering OAK Securities has, prior to the notification of this Announcement to the RNS, entered into the Placing Agreement with the Company under which OAK Securities has undertaken, on the terms and subject to the conditions set out therein, to use its reasonable endeavours as agent of the Company, to procure Placees for the Offering Shares. This Appendix gives details of the terms and conditions of, and the mechanics for participation in, the Offering. Each Placee's commitment to subscribe for Offering Shares under the Offering and to participate in the Bookbuild (as defined below) will be agreed (by email, orally or otherwise) with OAK Securities and such agreement will constitute a binding irrevocable commitment by a Placee, subject to the Terms and Conditions set out in this Appendix, to subscribe for and pay for Offering Shares at the Issue Price. Such commitment is not capable of variation, termination or rescission by the Placee in any circumstances except fraud. Upon such agreement, each Placee has an immediate, separate, irrevocable and binding obligation owed to OAK Securities, as agent for the Company, to pay OAK Securities (or as it may direct) in cleared funds an amount equal to the product of the Issue Price and the total number of Offering Shares such Placee has agreed to subscribe for in the Offering. All such obligations are entered into by the Placee with OAK Securities, acting in its capacity as agent of the Company, and are therefore directly enforceable by the Company. Each Placee's allocation of Offering Shares will be agreed between OAK Securities and the Company and will be confirmed by email or orally to each Placee by OAK Securities (as agent for the Company) as soon as possible following the closing of the Bookbuild and confirmed in writing, including the aggregate amount owed by such Placee to OAK Securities and settlement instructions ('Contract Confirmation'). The confirmation to such Placee by OAK Securities (as agent for the Company) constitutes an irrevocable legally binding commitment upon that person (who will at that point become a Placee) in favour of OAK Securities and the Company to subscribe for the number of Offering Shares allocated to it at the Issue Price on the terms and conditions set out in this Appendix and in accordance with the Company's articles of association. All obligations under the Offering will be subject to fulfilment of the conditions referred to below under 'Conditions of the Offering' and to the Offering not being terminated on the basis referred to below under 'Right to terminate the Placing Agreement'. By participating in Offering, each Placee agrees that its rights and obligations in respect of the Offering will terminate only in the circumstances described below and will not be capable of rescission or termination by the Placee. OAK Securities and its affiliates are entitled to enter bids as principal in the Offering. Irrespective of the time at which a Placee's allocation pursuant to the Offering is confirmed, settlement for all Offering Shares to be subscribed for pursuant to the Offering will be required to be made at the same time, on the basis explained below under 'Registration and Settlement'. The Company confirms that the Offering Shares will when issued, subject to the constitution of the Company, rank pari passu in all respects and form one class with the existing Common Shares of the Company in issue as at the date of this announcement, including the right to receive dividends or other distributions after the date of issue of the Offering Shares, if any. The Offering Shares are or will be issued free of any encumbrance, lien or other security interest. Applications for Admission The Company will apply for admission of the Offering Shares to trading on AIM to become effective on or around 29 August 2025. Bookbuild The Offering will be conducted through an accelerated bookbuilding process (the 'Bookbuild' or the 'Bookbuilding Process'), which will be launched immediately following this Announcement. The timing of the closing of the Bookbuild and allocations are at the absolute discretion of OAK Securities and the Company. It is currently envisaged that the result of the Bookbuilding Process will be announced via RNS on 21 August 2025 at or around 07:00 (UK time). Scaling back OAK Securities (after consulting with the Company) reserves the right to scale back the number of Offering Shares to be subscribed by any Placee or the number of Offering Shares to be subscribed for by all Placees in aggregate. OAK Securities also reserves the right not to offer allocations of Offering Shares to any person and not to accept offers to subscribe for Offering Shares or to accept such offers in part rather than in whole. OAK Securities shall be entitled to effect the Offering by such alternative method to the Bookbuild as it shall in its sole discretion lawfully determine in the exercise of its appointment and the powers, authority and discretion conferred on it as the sole broker. To the fullest extent permissible by law, neither OAK Securities nor any holding company of OAK Securities, nor any subsidiary, branch or affiliate of any of OAK Securities (each an 'Affiliate') nor any person acting on behalf of any of the foregoing shall have any liability to Placees (or to any other person whether acting on behalf of a Placee or otherwise). In particular, neither OAK Securities, nor any of its Affiliates nor any person acting on behalf of any such person shall have any liability to Placees in respect of its conduct of the Offering. Placing Agreement Pursuant to the Placing Agreement, OAK Securities has agreed on behalf of and as agent of the Company to use its reasonable endeavours to procure persons to subscribe for the Offering Shares at the Issue Price, subject to these Terms and Conditions. The Offering will not be underwritten. Conditions of the Offering The Offering is conditional upon the Placing Agreement becoming unconditional and not having been terminated in accordance with its terms. The obligations of OAK Securities under the Placing Agreement in respect of the Offering Shares are conditional, inter alia, on:- If any of the conditions contained in the Placing Agreement ('Conditions') are not fulfilled (by 26 September 2025 the Placing Agreement shall cease and determine. Right to terminate the Placing Agreement OAK Securities may, in its absolute discretion, terminate the Placing Agreement, where, at its sole discretion (but in consultation with the Company), due to a change in market, economic or financial conditions, the Offering is rendered temporarily or permanently impracticable or inadvisable. The exercise by OAK Securities of a right of termination (or any right of waiver) exercisable by OAK Securities contained in the Placing Agreement or the exercise of any discretion under the Terms and Conditions set out herein is within the absolute discretion of OAK Securities and OAK Securities will not have any liability to Placees whatsoever in connection with any decision to exercise or not exercise any such rights. By accepting the Offering Shares referred to in the Announcement to which this Appendix is annexed, each Placee agrees that, without having any liability to such Placee, OAK Securities may exercise the right: (i) to extend the time for fulfilment of any of the conditions in the Placing Agreement (provided that Placees' commitments are not extended beyond the Long Stop Date); (ii) to, in their absolute discretion, waive, in whole or in part, fulfilment of certain of the conditions (but not including Admission); or (iii) to terminate the Placing Agreement, in each case without consulting Placees (or any of them). If any of the conditions in the Placing Agreement are not satisfied (or, where relevant, waived), the Placing Agreement is terminated or the Placing Agreement does not otherwise become unconditional in all respects, the Offering will not proceed and all funds delivered by Placees to OAK Securities pursuant to the Offering and this Appendix will be returned to Placees at their risk (without interest), and Placees' rights and obligations under the Offering shall cease and determine at such time and no claim shall be made by Placees in respect thereof. Registration and Settlement Irrespective of the time at which the Placee's allocation(s) pursuant to the Offering is/are confirmed, settlement for all Offering Shares to be acquired pursuant to the Offering will be required to be made on the basis explained below. Settlement of transactions in the Offering Shares (ISIN: CA7459321039) following Admission will take place on a delivery versus payment basis in accordance with the instructions set out in the trade confirmation within the CREST system ('CREST') (subject to certain exceptions). OAK Securities reserves the right to require settlement for, and delivery of, the Offering Shares (or a portion thereof) to Placees by such other means that it may deem necessary if delivery or settlement is not possible or practicable within CREST within the timetable set out in the Announcement or would not be consistent with the regulatory requirements in the jurisdiction of any Placee. In order to enable Placees to settle their securities through CREST, the Company has appointed Computershare Investor Services Plc to act as a depositary (the 'Depositary') to hold the Common Shares and issue dematerialised depositary interests representing the underlying Common Shares ('Depositary Interests'). The Depositary will hold the Common Shares on trust for the relevant shareholders and this trust relationship is documented in a deed poll previously executed by the Depositary (the 'Deed Poll'). The Deed Poll set(s) out the procedure for holders of Depositary Interests to vote at general meetings and to exercise other procedural shareholder rights, which will be transferred to the Depositary with the Common Shares. The Depositary Interests will be independent English securities and will be held on a register maintained by the Depositary. The Depositary Interests will have the same security code and ISIN number as the underlying Common Shares which they represent and will not require a separate admission to AIM. Following despatch of Contract Confirmations, Placees will be required to confirm by email to OAK Securities (as agent for the Company) the CREST account details in their names or in the names of their CREST nominees to which their Offering Shares should be credited. It is expected that settlement for Offering Shares will take place at 8.00 a.m. on 29 August 2025 unless otherwise notified by OAK Securities. Interest is chargeable daily on payments not received from Placees on the due date in accordance with the arrangements set out above at the rate of 2 percentage points above the base rate of Barclays Bank Plc as determined by OAK Securities, with interest compounded on a daily basis. Each Placee is deemed to agree that, if it does not comply with these obligations, OAK Securities may sell any or all of the Offering Shares allocated to that Placee on such Placee's behalf and retain from the proceeds, for its account and benefit (as agent for the Company), an amount equal to the aggregate amount owed by the Placee plus any interest due. The relevant Placee will, however, remain liable for any shortfall below the aggregate amount owed by it and may be required to bear any stamp duty or stamp duty reserve tax or securities transfer tax (together with any interest or penalties) which may arise in any jurisdiction upon the sale of such Offering Shares on such Placee's behalf. By communicating a bid for Offering Shares, each Placee confers on OAK Securities all such authorities and powers necessary or desirable to carry out any such sale and agrees to ratify and confirm all actions which OAK Securities lawfully takes in pursuance of such sale. If Offering Shares are to be delivered to a custodian or settlement agent, Placees should ensure that the Contract Confirmation is copied and delivered immediately to the relevant person within that organisation. The Company confirms that, insofar as Offering Shares are registered in a Placee's name or that of its nominee or in the name of any person for whom a Placee is contracting as agent or that of a nominee for such person, such Offering Shares should, subject as provided below, be so registered free from any liability to UK stamp duty or stamp duty reserve tax or securities transfer tax. Placees will not be entitled to receive any fee or commission in connection with the Offering. Further Terms, Confirmations and Warranties By participating in the Offering, each Placee (and any person acting on such Placee's behalf) irrevocably makes the following confirmations, acknowledgements, representations, warranties and/or undertakings (as the case may be) to OAK Securities (in its capacity as sole broker and as agent of the Company) and the Company and their respective directors, agents and advisers, in each case as a fundamental term of its offer to acquire and subscribe for Offering Shares: The foregoing acknowledgements, agreements, undertakings, representations, warranties and confirmations are given for the benefit of the Company and OAK Securities (for their own benefit and, where relevant, the benefit of their respective officers and affiliates and any person acting on their behalf) and are irrevocable. Each Placee, and any person acting on behalf of a Placee, acknowledges that the neither the Company nor OAK Securities owes any fiduciary or other duties to any Placee in respect of any representations, warranties, undertakings or indemnities in the Placing Agreement. Responsibility The Terms and Conditions set out in this Appendix and the Announcement of which it forms part have been issued by the Company and are the sole responsibility of the Company. SOURCE: Pulsar Helium Inc. press release

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store